Current role
Biotechnology · Healthcare
Board Member
2020-01-01–present
Catherine Stehman-Breen
Board Member
Tenaya Therapeutics, Inc. (TNYA)Equibles does not estimate personal net worth.
Get an email with a short summary when Tenaya Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TNYA alertsAbout Catherine Stehman-Breen
Catherine Stehman-Breen is recorded as Board Member at Tenaya Therapeutics, Inc. (TNYA) since January 1, 2020. The newest filing on record that lists Catherine Stehman-Breen as Board Member at Tenaya Therapeutics, Inc. (TNYA) is dated April 16, 2026. Tenaya Therapeutics, Inc. reported in an 8-K filed May 29, 2026 that Catherine Stehman-Breen was appointed Class II Director, effective May 27, 2026. Tenaya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tenaya Therapeutics, Inc. includes Faraz Ali (CEO, CFO and Board Member), Eric Hyllengren (CFO), Chihiro Saito (Chief Accounting Officer) and 7 others.
“Each director nominee was duly elected to serve until the 2029 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.”
Affiliation history
-
Current
2020-01-01–present
Last confirmed April 16, 2026
Company network
Leadership on record at Tenaya Therapeutics, Inc.
- Faraz Ali CEO, CFO, Board Member
- Eric Hyllengren CFO
- Chihiro Saito Chief Accounting Officer
- Tomohiro Higa Chief Accounting Officer
- Amy Burroughs Board Member
- Continuing Directors Board Member
- Deepak Srivastava Board Member
- Jeffrey T. Walsh Board Member
- June Lee Board Member
- June Lee, M.D. Board Member